
AI drug-discovery company (Genesis Therapeutics) in the San Francisco Bay Area, whose GEMS platform combines deep learning and physics-based simulation for small-molecule discovery.
Current members 1
Based on public sources. If accuracy is important, verify details using the links or references.
For corrections, updates, or requests to remove information, contact us.



